---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-005694"
form_type: "8-K"
ticker: "VOR"
cik: "0001817229"
company_name: "Vor Biopharma Inc."
filed_at: "2022-04-14T23:59:59+00:00"
generated_at: "2026-06-26T07:26:52.406505+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Vor Biopharma CMO Christopher Slapak to retire effective May 6, 2022

## Summary
- Dr. Christopher Slapak, Chief Medical Officer, will terminate employment on May 6, 2022 due to retirement.
- Severance benefits consistent with the Company's Executive Severance and Change in Control Benefits Plan.
- Separation agreement to be filed as an exhibit to Q2 2022 Form 10-Q.
- No successor appointed as of the filing date.

## SEC filing metadata
- accession: 0000950170-22-005694
- form_type: 8-K
- ticker: VOR
- cik: 0001817229
- company_name: Vor Biopharma Inc.
- filed_at: 2022-04-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1817229/000095017022005694/0000950170-22-005694-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1817229/000095017022005694/vor-20220411.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-005694
- JSON: https://secwatch.observer/filing/0000950170-22-005694.json
- Plain text: https://secwatch.observer/filing/0000950170-22-005694.txt

## Key facts
- Executive change
  Christopher Slapak was terminated as Chief Medical Officer at Vor Biopharma Inc..
  - Action: terminated
  - Role: Chief Medical Officer
  source text: On April 11, 2022, Vor Biopharma Inc. (the “Company”) and Christopher Slapak, M.D., Chief Medical Officer of the Company, agreed that Dr. Slapak’s employment with the Company will terminate effective May 6, 2022 in connection with Dr. Slapak’s retirement from the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1817229/000095017022005694/0000950170-22-005694-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.